Quantcast
Last updated on April 16, 2014 at 16:51 EDT

Latest Blood disorders Stories

2012-04-13 05:28:27

(Ivanhoe Newswire) -- Around 80 percent of children with acute lymphoblastic leukemia (ALL) are now cured. With advancing treatment the cure rate may reach close to 90! Sounds promising right? According to a recent study, this figure is deceptive for children with unfavorable features defined by response to treatment or disease biology. In fact, some groups of children face a 50 percent cure rate. For example, a child with induction failure, where complete remission is not achieved after 4...

2012-04-12 09:20:25

International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks of intense chemotherapy known as induction therapy. The largest...

2012-04-11 10:24:16

International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation MEMPHIS, Tenn., April 11, 2012 /PRNewswire-USNewswire/ -- An international study found that bone marrow transplants are not the best option for some young patients with acute lymphoblastic leukemia (ALL) who fail to attain clinical remission after the initial weeks...

2012-04-09 09:38:11

A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans — even those resistant to conventional therapies — according to results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH). T-ALL is a cancer of the white blood cells in which genetic mutations cause normal immature...

2012-04-05 21:10:02

Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks. The advance in mice suggests that a combination approach to therapy might stamp out chronic myeloid leukemia (CML) for good. That's in contrast to the vast majority of CML patients taking drugs like imatinib (aka Gleevec) today, who often go into remission only to see their cancer return again. It is those lingering leukemia stem cells, which stubbornly...

2012-04-03 06:26:04

MIDLOTHIAN, Va., April 3, 2012 /PRNewswire-USNewswire/ -- Patient Services, Inc. (PSI), the "ground breaking" 501(c)(3) non-profit, charitable organization of its kind transitioned the bleeding disorders Patient Services Items program (PSIp) to the Hemophilia Federation of America's (HFA) long-time program, Helping Hands Emergency Assistance effective April 3, 2012. (Logo: http://photos.prnewswire.com/prnh/20120214/MM53649LOGO ) Since July 2003, PSI has had the privilege...

2012-04-03 09:05:24

The product, once available in the clinic, could be the first to hit a pathway that drives multiple types of lymphoma, according to new research from Fox Chase. Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings will be announced at the AACR Annual Meeting 2012 on Tuesday, April 3. "It's an exciting time to be involved in lymphoma treatment and research," says study...

2012-04-02 23:03:18

The Leukemia & Lymphoma Society's Silicon Valley Pineapple Classic 5k is a fun, family-friendly, Hawaiian-themed run with obstacles. Participants get dirty and have fun while helping to fight cancer. After the event on June 9, 2012, enjoy a celebration that will include a luau, beer garden and Hawaiian entertainment. San Jose, CA (PRWEB) April 02, 2012 The Leukemia & Lymphoma Society´s (LLS) Silicon Valley & Monterey Bay Area Chapter creates a unique kind of physical...

2012-04-01 23:02:37

Call for Sponsors for its Annual Event San Francisco, CA (PRWEB) March 31, 2012 Imagine weaving through the exotic and luxurious casinos that line the beaches of Monaco without stepping foot outside city limits! Stakes are high and jokers are wild at the 10th Annual Monte Carlo Night on Thursday, May 17th from 7:00pm to 1:00am at the legendary Yoshi´s Restaurant & Bar at 1330 Fillmore Street, San Francisco, CA 94115. An anticipated one thousand, 25-48 year old affluent,...

2012-03-30 10:22:19

KING OF PRUSSIA, Pa., March 30, 2012 /PRNewswire/ -- CSL Behring announced today the first in human dosing of recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP). The Phase I study will investigate in healthy volunteers the safety and pharmacokinetics of rVIIa-FP in comparison to placebo. CSL Behring, in collaboration with its parent company, CSL Limited (ASX: CSL), is developing rVIIa-FP, a novel therapy to treat hemophilia A and hemophilia B patients who have...